10 related articles for article (PubMed ID: 38733402)
1. Combination of nivolumab with standard induction chemotherapy in children and adults with EBV-positive nasopharyngeal carcinoma : Protocol of a prospective multicenter phase 2 trial.
Römer T; Vokuhl C; Staatz G; Mottaghy FM; Christiansen H; Eble MJ; Timmermann B; Klussmann JP; Elbracht M; Calaminus G; Zimmermann M; Brümmendorf TH; Feuchtinger T; Kerp H; Kontny U
HNO; 2024 Jun; 72(6):423-439. PubMed ID: 38214716
[TBL] [Abstract][Full Text] [Related]
2. Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical Trial.
Mai HQ; Chen QY; Chen D; Hu C; Yang K; Wen J; Li J; Shi Y; Jin F; Xu R; Pan J; Qu S; Li P; Hu C; Liu YC; Jiang Y; He X; Wang HM; Lim WT; Liao W; He X; Chen X; Wang S; Yuan X; Li Q; Lin X; Jing S; Chen Y; Lu Y; Hsieh CY; Yang MH; Yen CJ; Samol J; Luo X; Wang X; Tang X; Feng H; Yao S; Keegan P; Xu RH
JAMA; 2023 Nov; 330(20):1961-1970. PubMed ID: 38015220
[TBL] [Abstract][Full Text] [Related]
3. Induction chemotherapy regimes in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: A network meta-analysis and cost-effectiveness analysis.
Xu W; Qiu L; Li F; Fei Y; Wei Q; Shi K; Zhu Y; Luo J; Wu M; Yuan J; Liu H; Mao J; Cao Y; Zhou S; Guan X
Oral Oncol; 2024 May; 154():106865. PubMed ID: 38823173
[TBL] [Abstract][Full Text] [Related]
4. Incorporation of PD-1 blockade into induction chemotherapy improved tumor response in patients with locoregionally advanced nasopharyngeal carcinoma in a retrospective patient cohort.
Yao Y; Ouyang Q; Wang S; Li K; Luo Q; Qiu L; Liu F; Tan L; Li Q; Ren B; Long P; Ye J; Zhong X
Oral Oncol; 2024 May; 154():106867. PubMed ID: 38797001
[TBL] [Abstract][Full Text] [Related]
5. A nomogram based on the SII3 and clinical indicators predicts survival in patients with nasopharyngeal carcinoma treated with PD-1 inhibitors.
Chen X; Liang W; Wu X; Wang Y; Hong Y; Xie M; Han R; Lin Z
Medicine (Baltimore); 2024 May; 103(19):e38017. PubMed ID: 38728499
[TBL] [Abstract][Full Text] [Related]
6. SOX combined with sintilimab versus SOX alone in the perioperative management of locally advanced gastric cancer: a propensity score-matched analysis.
Huang X; Fang J; Huang L; Chen H; Chen H; Chai T; Ye Z; Chen H; Xu Q; Du Y; Yu P
Gastric Cancer; 2023 Nov; 26(6):1040-1050. PubMed ID: 37768447
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of adding PD-1 blockade to induction chemotherapy and concurrent chemoradiotherapy (IC-CCRT) for locoregionally advanced nasopharyngeal carcinoma: an observational, propensity score-matched analysis.
Jin YN; Qiang MY; Wang Y; Lin YJ; Jiang RW; Cao WW; Zhang WJ; Wang SY; Zhang HY; Yao JJ
Cancer Immunol Immunother; 2024 May; 73(7):125. PubMed ID: 38733402
[TBL] [Abstract][Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]